Feng JF - Search Results

1

MiR-138: A promising therapeutic target for cancer.

Sha HH, Wang DD, Chen D, Liu SW, Wang Z, Yan DL, Dong SC, Feng JF. Sha HH, et al. Among authors: feng jf. Tumour Biol. 2017 Apr;39(4):1010428317697575. doi: 10.1177/1010428317697575. Tumour Biol. 2017. PMID: 28378633 Free article. Review.

2

Long noncoding RNA HULC is a novel biomarker of poor prognosis in patients with pancreatic cancer.

Peng W, Gao W, Feng J. Peng W, et al. Med Oncol. 2014 Dec;31(12):346. doi: 10.1007/s12032-014-0346-4. Epub 2014 Nov 21. Med Oncol. 2014. PMID: 25412939

3

Long noncoding RNA SPRY4-IT1 predicts poor patient prognosis and promotes tumorigenesis in gastric cancer.

Peng W, Wu G, Fan H, Wu J, Feng J. Peng W, et al. Tumour Biol. 2015 Sep;36(9):6751-8. doi: 10.1007/s13277-015-3376-4. Epub 2015 Apr 3. Tumour Biol. 2015. PMID: 25835973

4

Comparison of nedaplatin-based versus cisplatin-based chemotherapy for advanced non-small cell lung cancer among East Asian populations: A meta-analysis.

Liu Y, Yu S, Liu S, Cao H, Ma R, Wu J, Feng J. Liu Y, et al. Sci Rep. 2015 May 21;5:10516. doi: 10.1038/srep10516. Sci Rep. 2015. PMID: 25994814 Free PMC article.

5

MicroRNA-377 predicts poor clinical outcome of gastric cancer and induces tumorigenesis by targeting multiple tumor-suppressor genes.

Wen X, Wu JQ, Peng W, Feng JF, Tang JH. Wen X, et al. Among authors: feng jf. Oncol Rep. 2015 Jul;34(1):203-10. doi: 10.3892/or.2015.3981. Epub 2015 May 15. Oncol Rep. 2015. PMID: 25998046

6

[Analysis of C.3925_3929 deletional mutations of APC gene in pedigrees with familial adenomatous polyposis].

Chen Q, Liu S, Feng J, Zhang X, Chen S, Ma G, Zhu M, Zhang Y, Yu J. Chen Q, et al. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2015 Aug;32(4):524-8. doi: 10.3760/cma.j.issn.1003-9406.2015.04.017. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2015. PMID: 26252100 Chinese.

7

MicroRNA-339, an epigenetic modulating target is involved in human gastric carcinogenesis through targeting NOVA1.

Shen B, Zhang Y, Yu S, Yuan Y, Zhong Y, Lu J, Feng J. Shen B, et al. FEBS Lett. 2015 Oct 7;589(20 Pt B):3205-11. doi: 10.1016/j.febslet.2015.09.009. Epub 2015 Sep 29. FEBS Lett. 2015. PMID: 26391641 Free article.

8

LXR ligands sensitize EGFR-TKI-resistant human lung cancer cells in vitro by inhibiting Akt activation.

Wu Y, Yu DD, Hu Y, Cao HX, Yu SR, Liu SW, Feng JF. Wu Y, et al. Among authors: feng jf. Biochem Biophys Res Commun. 2015 Nov 27;467(4):900-5. doi: 10.1016/j.bbrc.2015.10.047. Epub 2015 Oct 21. Biochem Biophys Res Commun. 2015. PMID: 26471306

9

WITHDRAWN: The long non-coding RNA, LINC00635-001, sensitizes EGFR-TKI-resistant human lung cancer cells in vitro by inhibiting Akt activation.

Wu Y, Yu DD, Hu Y, Yan DL, Chen X, Zhang HD, Cao HX, Yu SR, Wang Z, Feng JF. Wu Y, et al. Among authors: feng jf. Biochem Biophys Res Commun. 2016 Jan 11:S0006-291X(16)30057-2. doi: 10.1016/j.bbrc.2016.01.057. Online ahead of print. Biochem Biophys Res Commun. 2016. PMID: 26792719

10

Liver X receptor as a drug target for the treatment of breast cancer.

Wu Y, Yu DD, Yan DL, Hu Y, Chen D, Liu Y, Zhang HD, Yu SR, Cao HX, Feng JF. Wu Y, et al. Among authors: feng jf. Anticancer Drugs. 2016 Jun;27(5):373-82. doi: 10.1097/CAD.0000000000000348. Anticancer Drugs. 2016. PMID: 26872310 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

497 results

Search Page